Patents show all

57Applications29Issued

Clinical Trials show all

1Phase 1/Phase 2

SEC Filings show all

D2

SEC Form D Funding Events

DateOfferedSoldType
2009-09-15$17,384,210$10,003,426Equity, Security to be Acquired
2007-12-31UnknownUnknownOther (Paper Filing)

Key Executives

  • Frederic Chereau
    Executive Officer, Director
  • Helen M Nugent
    Executive Officer
  • Earl M Collier
    Director
  • Elazer R Edelman
    Director
  • Robert F Higgins
    Director
  • Peter B Hutt
    Director
  • Edwin M Kania
    Director
  • Robert S Langer
    Director
  • Frank Litvack
    Director
  • Amir Nashat
    Director
  • Yoram Richter
    Director